Nanosilver/DCOIT-containing surface coating effectively and constantly reduces microbial load in emergency room surfaces

Weber, J. and Henssler, L. and Zeman, F. and Pfeifer, C. and Alt, V. and Nerlich, M. and Huber, M. and Herbst, T. and Koller, M. and Schneider-Brachert, W. and Kerschbaum, M. and Holzmann, T. (2023) Nanosilver/DCOIT-containing surface coating effectively and constantly reduces microbial load in emergency room surfaces. JOURNAL OF HOSPITAL INFECTION, 135. pp. 90-97. ISSN 0195-6701, 1532-2939

Full text not available from this repository. (Request a copy)

Abstract

Background: Colonization of near-patient surfaces in hospitals plays an important role as a source of healthcare-associated infections. Routine disinfection methods only result in short-term elimination of pathogens. Aim: To investigate the efficiency of a newly developed antimicrobial coating containing nanosilver in long-term reduction of bacterial burden in hospital surfaces to close the gap between routine disinfection cycles. Methods: In this prospective, double-blinded trial, frequently touched surfaces of a routinely used treatment room in an emergency unit of a level-I hospital were treated with a surface coating (nanosilver/DCOIT-coated surface, NCS) containing nanosilver particles and another organic biocidal agent (4,5-dichloro-2-octyl-4-isothiazolin-3-one, DCOIT), whereas surfaces of another room were treated with a coating missing both the nanosilver-and DCOIT-containing ingredient and served as control. Bacterial contamination of the surfaces was examined using contact plates and liquid-based swabs daily for a total trial duration of 90 days. After incubation, total microbial counts and species were assessed. Findings: In a total of 2880 antimicrobial samples, a significant reduction of the overall bacterial load was observed in the NCS room (median: 0.31 cfu/cm2; interquartile range: 0.00-1.13) compared with the control coated surfaces (0.69 cfu/cm2; 0.06-2.00; P < 0.001). The nanosilver-and DCOIT-containing surface coating reduced the relative risk of a critical bacterial load (defined as >5 cfu/cm2) by 60% (odds ratio 0.38, P < 0.001). No significant difference in species distribution was detected between NCS and control group. Conclusion: Nanosilver-/DCOIT-containing surface coating has shown efficiency for sus-tainable reduction of bacterial load of frequently touched surfaces in a clinical setting. 2023 The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Item Type: Article
Uncontrolled Keywords: HEALTH-CARE FACILITIES; SILVER NANOPARTICLES; IN-VITRO; IMPLANTS; DISINFECTION; ENVIRONMENT; INFECTIONS; INHIBITION; RESISTANCE; STANDARDS; Nanosilver; Antimicrobial surface; Surface coating; Infection prevention; Nosocomial infections; Emergency room
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Unfallchirurgie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 08 Mar 2024 13:25
Last Modified: 08 Mar 2024 13:25
URI: https://pred.uni-regensburg.de/id/eprint/59162

Actions (login required)

View Item View Item